Trial Profile
Investigating New Onset Diabetes Mellitus in Kidney Transplant Recipients Receiving an Advagraf-Based Immunosuppressive Regimen With or Without Corticosteroids - A Multicenter, Two Arm, Randomized, Open Label Clinical Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Jan 2022
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Basiliximab; Methylprednisolone; Mycophenolate mofetil; Prednisolone
- Indications Renal transplant rejection
- Focus Adverse reactions
- Acronyms ADVANCE
- Sponsors Astellas Pharma
- 19 Aug 2016 Results published in the Transplantation
- 01 Feb 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Oct 2012 Planned End Date changed from 1 Sep 2012 to 1 Mar 2013 as reported by ClinicalTrials.gov.